Aprecia Pharmaceuticals Co — Form D/A

Aprecia Pharmaceuticals Co of LANGHORNE, PA, a company, filed a Form D amendment with the SEC on 2010-12-20. The offering totals $4.9M, of which $3.9M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Lawrence GlassmannDirectorCincinnati, OH
Joseph HighlandDirectorSkillman, NJ
Donald MonkhouseDirectorRadnor, PA
Etienne PeroldDirectorPennington, NJ
Michael KingExecutive OfficerROAD TOWN, TORTOLA, D8
Donald MonkhouseExecutive OfficerRadnor, PA
Etienne PeroldExecutive OfficerPennington, NJ
Henry SurprenantExecutive OfficerPhoenixville, PA
Jaedeok YooExecutive OfficerPrinceton, NJ
Etienne Thomas PeroldDirectorPennington, NJ
Michael Thomas RolhfsExecutive OfficerBlue Ash, OH
David Thomas FurnissExecutive OfficerMason, OH
Robert Thomas WillifordExecutive OfficerBlue Ash, OH
James Thomas EvansDirectorCincinnati, OH
Lawrence Thomas GlassmannDirectorBlue Ash, OH
Lawrence Thomas GlassmannExecutive OfficerBlue Ash, OH
E Thomas AringtonDirectorMason, OH
E Thomas AringtonExecutive OfficerMason, OH
Donald Thomas WetherholdExecutive OfficerBlue Ash, OH
Jonathan Thomas LeffDirectorNew York, NY
Michael Thomas RohlfsExecutive OfficerWest Chester, OH
DAVID A FURNISSExecutive OfficerCINCINNATI, OH
ROBERT A WILLIFORDExecutive OfficerCINCINNATI, OH
MICHAEL A ROHLFSExecutive OfficerWEST CHESTER, OH
Etienne A PeroldDirectorPennington, NJ

Other filings by this issuer (11)

FiledFormOfferingSold
2016-01-28D$84.0M$79.0M
2015-08-31D$52.0M$38.8M
2013-12-10D/A$36.3M$14.9M
2013-12-09D$36.2M$14.9M
2012-11-19D$8.6M$4.0M
2011-11-04D$25.7M$25.7M
2010-11-08D/A$455K$455K
2010-10-18D$105K$105K
2010-01-25D/A$5.5M$5.5M
2009-12-24D$2.5M$2.5M
2009-05-29D$500K$500K

More